The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
928
August 5, 1994
View Complete Issue         Table of Contents 2019 
Rocuronium - A New Neuromuscular Blocker
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Rocuronium - A New Neuromuscular Blocker
August 5, 1994 (Issue: 928)
Rocuronium bromide (Zemuron - Organon), a new short-onset, intermediate-acting, nondepolarizing neuromuscular blocking drug, is now available in the USA for intravenous use. It is being promoted particularly for use in rapid endotracheal...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Rocuronium - A New Neuromuscular Blocker
Article code: 928c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.